| Company | Role | Class | Num Shares | Value | Price $ | Report Date | Ownership |
|---|---|---|---|---|---|---|---|
| Poseida Therapeutics, Inc. | Director | Common Stock | 0 | $0 | $9.60 | 08 Jan 2025 | Direct |
| Poseida Therapeutics, Inc. | Director | Stock Option (Right to Buy) | 0 | 08 Jan 2025 | Direct |
| Symbol | Company | Period | Transactions | Value $ | Form Type | Role | Filing Time |
|---|---|---|---|---|---|---|---|
| /report/000141588925001087-lloyd-marcea-bland-2025-01-08 | Poseida Therapeutics, Inc. | 08 Jan 2025 | 9 | $0 | 4 | Director | 08 Jan 2025, 14:15 |
| /report/000095017024074873-lloyd-marcea-bland-2024-06-17 | Poseida Therapeutics, Inc. | 17 Jun 2024 | 2 | $0 | 4 | Director | 18 Jun 2024, 16:16 |
| /report/000095017023028606-lloyd-marcea-bland-2023-06-15 | Poseida Therapeutics, Inc. | 15 Jun 2023 | 2 | $0 | 4 | Director | 16 Jun 2023, 16:09 |
| /report/000120919122037664-lloyd-marcea-bland-2022-06-16 | Poseida Therapeutics, Inc. | 16 Jun 2022 | 2 | $0 | 4 | Director | 16 Jun 2022, 20:54 |
| /report/000120919121048257-lloyd-marcea-bland-2021-07-23 | Poseida Therapeutics, Inc. | 23 Jul 2021 | 1 | $0 | 4 | Director | 26 Jul 2021, 20:31 |
| /report/000120919121041515-lloyd-marcea-bland-2021-06-16 | Poseida Therapeutics, Inc. | 16 Jun 2021 | 1 | $0 | 4 | Director | 17 Jun 2021, 17:03 |